Latest Breaking News On - Received european orphan drug designation - Page 1 : comparemela.com

Decibel Therapeutics Reports First Quarter 2023 Financial Results and Corporate Update

- Initiated CHORD™, a global Phase 1/2 dose escalation clinical trial of lead gene therapy product candidate, DB-OTO - - Announced approval from the U.K. MHRA and Spanish AEMPS for CTAs for. | May 15, 2023

United statesChris raileyJulie seidelMatthew kapustaLaurence reidExchange commissionEuropean medicines agencyBridge communicationsCompany phaseDecibel therapeutics incEuropean unionStern ir incCommittee on orphan medicinal productsGood laboratory practicesSpanish agency of medicinesRegeneron pharmaceuticals

Cellectar Reports Financial Results for the First Quarter 2021 and Provides a Corporate Update

Cellectar Reports Financial Results for the First Quarter 2021 and Provides a Corporate Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesJames carusoCellectar biosciencesMonique kossemanaging directorlifesciEuropean commissionCellectar biosciences incExchange commissionDevelopment expenseReceived european orphan drug designationRecent corporateOrphan drug designationIntellectual propertyEther analogsCancer targeting drug vehiclesCash equivalentsAdministrative expenses